emerg
reemerg
pathogen
repres
substanti
threat
public
health
demonstr
numer
outbreak
past
year
includ
outbreak
ebola
viru
western
africa
coronavirus
also
threat
human
evidenc
infect
sever
acut
respiratori
syndrom
coronaviru
sarscov
caus
human
infect
fatal
rate
countri
ten
year
later
novel
human
coronaviru
middl
east
respiratori
syndrom
coronaviru
merscov
associ
sever
pneumonia
aros
kingdom
saudi
arabia
decemb
mer
account
case
fatal
rate
find
anim
model
diseas
key
develop
vaccin
antivir
emerg
pathogen
understand
pathogenesi
knowledg
potenti
role
domest
livestock
anim
speci
transmiss
pathogen
import
understand
epidemiolog
diseas
littl
known
merscov
anim
host
rang
paper
experiment
data
potenti
host
merscov
review
advantag
limit
differ
anim
model
evalu
relat
viral
pathogenesi
transmiss
studi
final
relev
potenti
new
target
speci
discuss
past
year
outbreak
zoonot
diseas
grow
resist
antibiot
emphas
need
interdisciplinari
collabor
human
health
veterinari
medicin
environment
scienc
concept
commonli
known
one
health
emerg
diseas
zoonot
instanc
human
flu
pandem
origin
domest
anim
wildlif
driven
ecolog
behavior
socioeconom
chang
case
reaction
time
detect
new
outbreak
applic
medic
countermeasur
critic
term
epidem
control
understand
potenti
role
anim
sourc
could
play
viru
dissemin
epidemiolog
diseas
surveil
studi
well
experiment
infect
potenti
target
speci
requir
furthermor
identifi
novel
reemerg
viru
respons
outbreak
import
rapidli
provid
accur
diagnosi
basi
quarantin
measur
also
imper
focu
search
new
vaccin
treatment
highli
pathogen
virus
especi
repres
threat
human
anim
health
particularli
livestock
begin
last
decad
human
coronavirus
hcov
infect
consid
restrict
upper
respiratori
tract
urt
low
mortal
rate
recogn
second
rank
caus
common
cold
rhinovirus
howev
sever
acut
respiratori
syndrom
coronaviru
sarscov
emerg
china
rapidli
spread
worldwid
causal
lethal
rate
ten
year
later
novel
hcov
associ
sever
pneumonia
emerg
kingdom
saudi
arabia
new
cov
name
middl
east
respiratori
syndrom
coronaviru
merscov
march
total
case
fatal
record
one
month
later
april
increas
human
case
regist
least
infect
peopl
fatal
recent
decemb
case
merscov
report
world
health
organ
includ
least
death
besid
coronavirus
highli
pathogen
virus
belong
famili
repres
threat
either
human
anim
health
one
recent
exampl
outbreak
ebola
viru
filovirida
west
africa
start
decemb
guinea
evolv
largest
ebola
outbreak
record
case
furthermor
recent
year
outbreak
caus
emerg
viral
pathogen
arenavirida
bunyavirida
flavivirida
famili
among
other
disturb
public
privat
health
social
network
economi
affect
countri
prevent
control
emerg
reemerg
viral
diseas
effici
sever
action
combin
ie
creat
diagnost
network
surveil
program
train
medic
veterinari
staff
inform
popul
sanitari
measur
also
promot
research
prophylaxi
treatment
caus
agent
pathogenesi
regard
last
point
anim
model
crucial
studi
viral
host
factor
contribut
diseas
well
transmiss
outcom
viru
infect
allow
preclin
test
antivir
drug
vaccin
nonhuman
primat
nhp
prefer
model
pathogenesi
studi
potenti
vaccin
treatment
test
better
translat
human
howev
work
nhp
costli
limit
avail
rais
ethic
problem
therefor
smallanim
model
usual
first
choic
drug
screen
unit
state
food
drug
administr
fda
anim
rule
provid
guidelin
concern
appropri
anim
model
licens
purpos
addit
control
diseas
anim
reservoir
andor
intermedi
host
viru
transmiss
human
significantli
reduc
particularli
true
domest
feral
anim
effici
vaccin
vaccin
strategi
implement
therefor
case
new
pathogen
viru
outbreak
search
natur
host
potenti
target
anim
oppos
laboratori
anim
seem
relev
implement
prophylact
solut
also
improv
prepared
eventu
global
extens
diseas
nowaday
task
render
possibl
avail
improv
biosafeti
level
anim
facil
accommod
larg
anim
experiment
highli
virul
pathogen
articl
current
situat
comprehens
potenti
host
merscov
review
base
coronavirus
experi
benefit
limit
speci
anim
model
transmiss
studi
discuss
sever
review
articl
describ
discuss
anim
model
merscov
infect
section
current
statu
anim
model
mer
diseas
reproduct
briefli
summar
identif
merscov
effort
direct
develop
anim
model
studi
pathogenesi
test
efficaci
vaccin
andor
treatment
vivo
similar
sarscov
rhesu
macaqu
demonstr
suscept
merscov
work
led
munster
demonstr
common
marmoset
also
suitabl
merscov
model
show
model
recapitul
diseas
observ
human
therefor
find
evalu
potenti
therapeut
strategi
might
implement
human
howev
small
anim
requir
control
larg
comprehens
studi
first
experi
sarscov
turn
help
research
merscov
develop
small
anim
model
mer
difficult
task
raj
collabor
rapidli
identifi
dipeptidyl
function
receptor
merscov
present
lung
cell
mani
rodent
thu
rodent
expect
suscept
merscov
howev
predict
crystal
structur
analysi
merscov
receptor
bind
domain
rbd
human
extracellular
domain
far
rodent
model
natur
permiss
merscov
infect
syrian
hamster
receptor
shown
express
bronchiolar
epithelium
inocul
merscov
via
aerosol
intratrach
rout
differ
dose
lead
product
infect
wild
type
immunedefici
mice
also
test
merscov
infect
without
success
sinc
sever
group
focus
new
strategi
develop
small
anim
model
suscept
merscov
infect
found
mous
cell
could
made
permiss
merscov
express
consequ
transduc
mous
lung
use
adenoviru
vector
result
anim
suscept
merscov
infect
mice
exhibit
pneumonia
extens
inflammatorycel
infiltr
presenc
viru
lung
recent
transgen
mice
model
express
highli
suscept
merscov
infect
abl
display
system
lesion
develop
demonstr
sever
diseas
transgen
anim
model
becom
import
tool
improv
medic
research
hand
glycosyl
murin
major
factor
impact
receptor
function
block
bind
merscov
therefor
modif
mous
genom
match
sequenc
made
speci
suscept
merscov
infect
accordingli
newli
establish
mice
model
use
evalu
efficaci
vaccin
therapeut
agent
merscov
infect
velocimmun
velocigen
technolog
use
develop
human
mous
model
merscov
infect
methodolog
also
appli
pathogen
futur
emerg
epidem
research
worldwid
identifi
sever
anim
speci
could
role
transmiss
merscov
human
summar
fig
bat
suggest
reservoir
merscov
rna
merslik
cov
merscov
found
sever
bat
famili
vespertillionida
molosida
nycterida
emballonurida
africa
america
asia
europ
recent
experiment
infect
jamaican
fruit
bat
artibeu
jamaicensi
confirm
merscov
replic
bat
howev
merscov
strain
caus
diseas
human
far
identifi
bat
presenc
merscov
neutral
antibodi
report
dromedari
camel
camelu
dromedari
recent
link
merscov
infect
camel
human
infect
qatar
suggest
importantli
merscov
strain
caus
human
outbreak
found
dromedari
camel
fact
phylogenet
analys
indic
merscov
gener
speci
recombin
addit
adney
collabor
provid
experiment
evid
support
role
dromedari
camel
merscov
reservoir
recent
evid
provid
member
camelida
famili
alpaca
vicugna
paco
llama
lama
glama
also
suscept
merscov
infect
field
studi
alpaca
perform
qatar
confirm
find
recent
publish
experiment
studi
demonstr
domest
pig
also
suscept
merscov
infect
suggest
possibl
merscov
circul
unsuspect
anim
speci
suida
silico
predict
vitro
studi
suggest
livestock
speci
goat
sheep
hors
could
suscept
merscov
infect
experiment
data
suggest
opposit
natur
potenti
host
merscov
infect
discuss
detail
summar
tabl
dromedari
camel
main
sourc
merscov
zoonot
transmiss
review
experiment
intranas
inocul
merscov
mild
clinic
sign
ie
nasal
discharg
urt
infect
observ
viral
rna
detect
nasal
swab
upper
lower
respiratori
tract
also
extrapulmonari
tissu
ie
lymph
node
tonsil
intestin
liver
adren
gland
etc
contrast
infecti
viru
detect
urt
trachea
larg
bronchu
tracheobronchi
lymph
node
gross
lesion
observ
dromedari
camel
inflamm
nasal
caviti
trachea
bronchu
present
viru
replic
dromedari
detect
epitheli
cell
urt
llama
alpaca
also
known
domest
new
world
camelid
develop
similar
clinicalpatholog
pictur
dromedari
experiment
merscov
infect
speci
viru
inocul
via
intranas
rout
either
clinic
sign
alpaca
mild
mucu
secret
llama
observ
merscov
detect
nasal
swab
urt
trachea
llama
alpaca
none
speci
show
lesion
macroscop
microscop
mild
sever
rhiniti
detect
alpaca
well
metaplasia
epithelium
turbin
alpaca
similar
dromedari
epitheli
cell
urt
main
target
cell
viru
replic
concomit
antibodi
respons
viru
clear
urt
day
experiment
infect
intranas
inocul
merscov
mild
excret
mucu
observ
old
domest
pig
viral
rna
detect
nasal
swab
urt
trachea
bronchu
although
gross
lesion
present
pig
show
mild
moder
rhiniti
viru
replic
observ
epitheli
cell
urt
shed
merscov
detect
nasal
swab
day
pi
infecti
viru
detect
day
pi
viral
rna
also
detect
urt
trachea
bronchu
cov
dromedari
camel
demonstr
reservoir
merscov
speci
might
act
host
red
report
merscovseroposit
speci
andor
speci
viru
natur
detect
orang
anim
speci
might
consid
potenti
host
sinc
experiment
suscept
merscov
infect
alpaca
fit
scenario
red
orang
black
anim
bat
date
rna
differ
sequenc
merscovlik
virus
found
continu
arrow
repres
alreadi
describ
intraand
interspeci
transmiss
event
discontinu
arrow
repres
potenti
interspeci
transmiss
new
zealand
white
rabbit
exhibit
clinic
sign
signific
gross
lesion
necropsi
experiment
merscov
inocul
thu
consid
anim
model
asymptomat
infect
similar
pig
mild
moder
rhiniti
necrosi
observ
respiratori
epitheli
cell
urt
identifi
target
cell
merscov
replic
viral
rna
present
nasal
swab
upper
lower
respiratori
tract
infecti
viru
also
detect
nasal
swab
day
pi
rhesu
macaqu
use
first
anim
model
develop
merscov
infect
show
mild
moder
respiratori
diseas
day
pi
intratrach
inocul
gross
lesion
present
lung
consist
congest
presenc
nodul
main
observ
microscop
lesion
interstiti
pneumonia
although
merscov
rna
detect
nasal
swab
bronchoalveolar
lavag
sampl
oropharyng
swab
also
upper
lower
respiratori
tract
tissu
sampl
infecti
viru
isol
lung
merscov
replic
occur
type
ii
pneumocyt
viral
antigen
coloc
site
pneumonia
macaqu
repres
use
model
studi
mild
merscov
infect
develop
transient
respiratori
diseas
similar
human
hand
common
marmoset
exhibit
moder
sever
respiratori
diseas
day
inocul
merscov
multipl
rout
ocular
oral
intratrach
intranas
similar
macaqu
gross
find
present
lung
mild
sever
respiratori
diseas
diffus
interstiti
infiltr
lower
lung
lobe
bronchointerstiti
pneumonia
type
pneumocyt
alveolar
macrophag
abbrevi
nhp
nonhuman
primat
urt
upper
respiratori
tract
also
anim
model
diseas
translat
human
correl
moder
sever
bronchointerstiti
pneumonia
merscov
antigen
detect
immunohistochemistri
type
ii
pneumocyt
alveolar
macrophag
viru
replic
type
pneumocyt
macrophag
similar
result
observ
marmoset
inocul
merscov
via
intratrach
rout
howev
outcom
merscov
infect
marmoset
controversi
public
recent
studi
johnson
collabor
demonstr
lethal
intratrach
inocul
outcom
experiment
infect
speci
review
recent
public
describ
previou
section
number
anim
speci
describ
either
natur
reservoir
dromedari
camel
potenti
intermedi
host
merscov
one
benefit
limit
tabl
use
experiment
infect
model
camelid
dromedari
camel
alpaca
llama
noncamelid
domest
speci
pig
rabbit
nhp
rhesu
macaqu
common
marmoset
experiment
demonstr
suscept
merscov
infect
differ
among
experi
dromedari
camel
natur
merscov
host
probabl
first
target
control
mer
vaccin
costli
repres
high
secur
risk
anim
caretak
difficulti
handl
anim
appropri
biosafeti
condit
main
advantag
use
llama
alpaca
model
belong
famili
camelida
smaller
size
gentl
behavior
avail
commerci
level
dromedari
camel
importantli
specif
reagent
immun
monitor
develop
new
world
camelid
therefor
may
use
surrog
dromedari
experiment
condit
howev
model
also
quit
expens
requir
larg
complex
facil
contrast
camelid
domest
speci
pig
rabbit
readili
avail
lower
cost
easier
handl
addit
extens
panel
specificimmunolog
reagent
avail
speci
compar
camelid
howev
lower
merscov
titer
detect
nasal
caviti
tissu
sampl
pig
rabbit
infect
furthermor
use
anim
model
transmiss
studi
yet
address
contrari
mention
speci
macaqu
common
marmoset
develop
clinic
diseas
rel
similar
human
respect
phylogeneticallyrel
speci
baboon
live
africa
arab
peninsula
might
also
play
role
transmiss
viru
howev
littl
attent
paid
speci
sinc
seroepidemiolog
document
import
limit
work
nhp
model
name
complex
husbandri
requir
lead
substanti
increas
cost
controversi
result
among
differ
group
besid
practic
consider
humanspecif
immunolog
reagent
crossreact
nhp
speci
wide
avail
summar
review
sever
speci
anim
suscept
experiment
merscov
infect
thu
might
act
potenti
intermedi
host
diseas
howev
presenc
viral
rna
andor
specif
antibodi
viru
demonstr
field
dromedari
alpaca
light
recent
experiment
studi
seem
list
potenti
host
target
merscov
close
mer
surveil
program
implement
endem
area
anim
speci
experiment
evid
suscept
provid
speci
close
relat
sar
mer
outbreak
taught
us
mani
lesson
one
import
even
absenc
overt
threat
possibl
reemerg
viru
similar
virus
hand
sinc
first
case
mer
continu
new
case
describ
differ
countri
around
world
underlin
import
develop
anim
model
closer
natur
host
target
key
role
domest
anim
wildlif
transmiss
merscov
elucid
meanwhil
countermeasur
deadli
coronavirus
must
explor
sinc
risk
global
outbreak
neglig
noteworthi
decad
sar
five
year
mer
epidem
still
licens
prevent
therapeut
drug
avail
could
use
case
eventu
reemerg
sar
mer
scenario
outcom
technic
issu
sinc
effect
vaccin
prototyp
pathogen
alreadi
avail
case
merscov
vaccin
dromedari
camel
main
sourc
zoonot
transmiss
might
use
control
spread
mer
howev
develop
vaccin
besid
test
protect
efficaci
research
need
think
social
problem
retic
camel
owner
vaccin
anim
thu
develop
dual
vaccin
abl
protect
merscov
camelpox
viru
endem
diseas
middl
east
africa
asia
might
ideal
solut
recent
anoth
dualvaccin
human
anim
merscov
rabi
viru
design
polit
aspect
also
key
role
releas
vaccin
market
unless
requir
time
vaccin
licens
procedur
facilit
pharmaceut
compani
unlik
invest
develop
take
account
current
market
demand
moreov
fragment
intellectu
properti
right
may
also
advers
affect
develop
vaccin
combat
infect
none
